Chinook Therapeutics U.S., Inc.
Biotechnology company · Seattle, Washington, United States
Chinook Therapeutics U.S., Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $115 million sold in a notice filed in 2020.
Chinook Therapeutics U.S. at a glance
What does Chinook Therapeutics U.S. do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $115 million sold (2020).
Frequently asked questions about Chinook Therapeutics U.S.
Where is Chinook Therapeutics U.S. headquartered?
Chinook Therapeutics U.S., Inc. is headquartered in Seattle, Washington, United States.
What does Chinook Therapeutics U.S. do?
Chinook Therapeutics U.S., Inc. is a biotechnology company.
When was Chinook Therapeutics U.S. founded?
The earliest incorporation on record for Chinook Therapeutics U.S., Inc. is in 2018, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences